Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI.

Sirajuddin P, Das S, Ringer L, Rodriguez OC, Sivakumar A, Lee YC, √úren A, Fricke ST, Rood B, Ozcan A, Wang SS, Karam S, Yenugonda V, Salinas P, Petricoin E 3rd, Pishvaian M, Lisanti MP, Wang Y, Schlegel R, Moasser B, Albanese C.

Cell Cycle. 2012 Oct 15;11(20):3801-9. doi: 10.4161/cc.21988. Epub 2012 Sep 14.

PMID:
22983062
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG).

Yalon M, Rood B, MacDonald TJ, McCowage G, Kane R, Constantini S, Packer RJ.

Pediatr Blood Cancer. 2013 Jan;60(1):71-6. doi: 10.1002/pbc.24142. Epub 2012 Mar 20.

PMID:
22434731
[PubMed - indexed for MEDLINE]
3.

Quality of life for children with life-limiting and life-threatening illnesses: description and evaluation of a regional, collaborative model for pediatric palliative care.

Rogers SK, Gomez CF, Carpenter P, Farley J, Holson D, Markowitz M, Rood B, Smith K, Nigra P.

Am J Hosp Palliat Care. 2011 May;28(3):161-70. doi: 10.1177/1049909110380594. Epub 2010 Sep 8.

PMID:
20826494
[PubMed - indexed for MEDLINE]
4.

Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan.

Packer RJ, Jakacki R, Horn M, Rood B, Vezina G, MacDonald T, Fisher MJ, Cohen B.

Pediatr Blood Cancer. 2009 Jul;52(7):791-5. doi: 10.1002/pbc.21935.

PMID:
19165892
[PubMed - indexed for MEDLINE]
5.

Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.

Choi LM, Rood B, Kamani N, La Fond D, Packer RJ, Santi MR, Macdonald TJ.

Pediatr Blood Cancer. 2008 May;50(5):970-5.

PMID:
17941070
[PubMed - indexed for MEDLINE]
6.

Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.

Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.

Pediatr Blood Cancer. 2007 Mar;48(3):278-84.

PMID:
16456857
[PubMed - indexed for MEDLINE]
7.

Atypical background somatic mutant frequencies at the HPRT locus in children and adults with Down syndrome.

Finette BA, Rood B, Poseno T, Vacek P, Pueschel S, Homans AC.

Mutat Res. 1998 Jul 17;403(1-2):35-43.

PMID:
9726004
[PubMed - indexed for MEDLINE]
8.

Visual speech aids: a British survey of use and evaluation by speech and language therapists.

Coventry KR, Clibbens J, Cooper M, Rood B.

Eur J Disord Commun. 1997;32(3 Spec No):203-16.

PMID:
9474289
[PubMed - indexed for MEDLINE]
9.

Bias in conditional inference: implications for mental models and mental logic.

Evans JS, Clibbens J, Rood B.

Q J Exp Psychol A. 1995 Aug;48(3):644-70.

PMID:
7568994
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk